Although tau pathology is most prominently associated with classical tauopathies, growing evidence suggests that it also contributes to synucleinopathies, including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) [1, 11, 12]. This evidence concerns the gene MAPT and Parkinson disease.